IPSC · Company research
Century Therapeutics, Inc. Common Stock (IPSC): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A cell-therapy company will attend a London conference on Nov. 18 - Stock Titan | A cell-therapy company will attend a London conference on Nov. 18 Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Century Therapeutics stock fell 10.81 percent on October 6 - AD HOC NEWS | Century Therapeutics stock fell 10.81 percent on October 6 AD HOC NEWS | View source ↗ | AD HOC NEWS | Oct 7, 2026 | neutral | 0 | 0.6 |
| $IPSC stock is down 9% today. Here's what we see in our data. - Quiver Quantitative | $IPSC stock is down 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 6, 2026 | neutral | 0 | 0.6 |
| Century Therapeutics advances CNTY-813 islet therapy program - The Globe and Mail | Century Therapeutics advances CNTY-813 islet therapy program The Globe and Mail | View source ↗ | The Globe and Mail | Oct 3, 2026 | neutral | 0 | 0.6 |
| Diabetic mice kept normal blood sugar until the transplant was removed. The study lasted over 11 months. - Stock Titan | Diabetic mice kept normal blood sugar until the transplant was removed. The study lasted over 11 months. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet (NASDAQ:IPSC) - Seeking Alpha | Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet (NASDAQ:IPSC) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 30, 2026 | neutral | 0 | 0.6 |
| Century Therapeutics (IPSC) exec sale covers RSU taxes - Stock Titan | Century Therapeutics (IPSC) exec sale covers RSU taxes Stock Titan | View source ↗ | Stock Titan | Sep 15, 2026 | neutral | 0 | 0.6 |
| Two cell therapies head toward 2026 milestones. One targets type 1 diabetes. - Stock Titan | Two cell therapies head toward 2026 milestones. One targets type 1 diabetes. Stock Titan | View source ↗ | Stock Titan | Sep 9, 2026 | neutral | 0 | 0.6 |
| Will Century Therapeutics (NASDAQ:IPSC) Spend Its Cash Wisely? - Simply Wall Street | Will Century Therapeutics (NASDAQ:IPSC) Spend Its Cash Wisely? Simply Wall Street | View source ↗ | Simply Wall Street | Jul 16, 2026 | neutral | 0 | 0.6 |
| Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses - Yahoo Finance | Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses Yahoo Finance | View source ↗ | Yahoo Finance | Jul 14, 2026 | neutral | 0 | 0.6 |
| Century: 'Hold' Based On CNTY-101 Pivot And CNTY-813 T1D Curative Potential - Seeking Alpha | Century: 'Hold' Based On CNTY-101 Pivot And CNTY-813 T1D Curative Potential Seeking Alpha | View source ↗ | Seeking Alpha | Jul 9, 2026 | neutral | 0 | 0.6 |
| Here's Why We're Watching Century Therapeutics' (NASDAQ:IPSC) Cash Burn Situation - Yahoo Finance | Here's Why We're Watching Century Therapeutics' (NASDAQ:IPSC) Cash Burn Situation Yahoo Finance | View source ↗ | Yahoo Finance | Jun 13, 2026 | neutral | 0 | 0.6 |
| Century Therapeutics: A Biotech With Interesting Optionality Opportunities (NASDAQ:IPSC) - Seeking Alpha | Century Therapeutics: A Biotech With Interesting Optionality Opportunities (NASDAQ:IPSC) Seeking Alpha | View source ↗ | Seeking Alpha | Apr 24, 2026 | neutral | 0 | 0.6 |
| Century Therapeutics, Inc. Common Stock (IPSC) Stock - Gotrade | Century Therapeutics, Inc. Common Stock (IPSC) Stock Gotrade | View source ↗ | Gotrade | Jan 15, 2026 | neutral | 0 | 0.6 |
| There's No Escaping Century Therapeutics, Inc.'s (NASDAQ:IPSC) Muted Revenues Despite A 32% Share Price Rise - Simply Wall Street | There's No Escaping Century Therapeutics, Inc.'s (NASDAQ:IPSC) Muted Revenues Despite A 32% Share Price Rise Simply Wall Street | View source ↗ | Simply Wall Street | Dec 17, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.